Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells

Colloids and Surfaces B: Biointerfaces

Volumn 110, Issue , 2013, Pages 434-442

  Villa, Raffaella ^a   Cerroni, Barbara ^b   Viganò, Lucia ^a,c   Margheritelli, Silvia ^b   Abolafio, Gabriella ^a   Oddo, Letizia ^b   Paradossi, Gaio ^b   Zaffaroni, Nadia ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Asialoglycoprotein receptors; Chitosan; Drug release; Hepatocarcinoma; Microbubbles; Targeted drug delivery

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTORS; DRUG RELEASE; HEPATOCARCINOMA; MICROBUBBLES; TARGETED DRUG DELIVERY;

CELL CULTURE; CHITOSAN; CYTOTOXICITY; DRUG DELIVERY; DRUG PRODUCTS; FIBROBLASTS; POLYVINYL ALCOHOLS; ULTRASONICS;

POLYMERS;

ASIALOGLYCOPROTEIN RECEPTOR; CHITOSAN DERIVATIVE; DOXORUBICIN; DRUG CARRIER; ECHO CONTRAST MEDIUM; POLYMER; POLYVINYL ALCOHOL;

ARTICLE; CARCINOMA CELL; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; DRUG UPTAKE; FIBROBLAST; GALACTOSYLATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MICROBUBBLE; OSCILLATION; PRIORITY JOURNAL; ULTRASOUND;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CELLS, CULTURED; CHITOSAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; GALACTOSE; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICROBUBBLES; MOLECULAR STRUCTURE; POLYMERS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84879496674     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.04.022     Document Type: Article

References (44)

1. Singh S.J. J. Nanosci. Nanotechnol. 2010, 10:7906.
2. Kaneda Y. Expert. Opin. Drug Deliv. 2010, 7:1079.
3. Wu C.H., Wu G.Y. Adv. Drug. Deliv. Rev. 1998, 29:243.
4. Ashwell G., Harford J. Annu. Rev. Biochem. 1982, 51:531.
5. Hara T., Aramaki Y., Takada S., Koike K., Tsuchiya S. Gene 1995, 159:167.
6. Kawakami S., Yamashita F., Nishikawa M., Takakura Y., Hashida M. Biochem. Biophys. Res. Commun. 1998, 252:78.
7. Köping-Höggård M., Vårum K.M., Issa M., Danielsen S., Christensen B.E., Stokke B.T., Artursson P. Gene Ther. 2004, 11:1441.
8. Mansouri S., Cuie Y., Winnik F., Shi Q., Lavigne P., Benderdour M., Beaumont E., Fernandes J.C. Biomaterials 2006, 27:2060.
9. Zhang H., Mardyani S., Chan W.C., Kumacheva E. Biomacromology 2006, 7:1568.
10. Kim T.H., Nah J.W., Cho M.H., Park T.G., Cho C.S. J. Nanosci. Nanotechnol. 2006, 6:2796.
11. Kim T.H., Park I.K., Nah J.W., Choi Y.J., Cho C.S. Biomaterials 2004, 25:3783.
12. Jiang H.L., Kim Y.K., Lee S.M., Park M.R., Kim E.M., Jin Y.M., Arote R., Jeong H.J., Song S.C., Cho M.H., Cho C.S. Arch. Pharm. Res. 2010, 33:551.
13. Shutt E.G., Klein D.H., Mattrey R.M., Riess J.G. Angew. Chem. Int. Ed. 2003, 42:3218.
14. Feinstein S.B. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:450.
15. Cavalieri F., Hamassi El A., Chiessi E., Paradossi G. Langmuir 2005, 21:8758.
16. Paradossi G., Cavalieri F., Chiessi E., Spagnoli C., Cowman M.K. J. Mater. Sci. Mater. Med. 2003, 14:687.
17. Cavalieri F., Miano F., D'Antona P., Paradossi G. Biomacromology 2004, 5:2439.
18. Tortora M., Oddo L., Margheritelli S., Paradossi G. Ultrasound Contrast Agents 2010, Springer-Verlag, Milan, (Chapter 3).
19. Grishenkov D., Kari L., Brodin L.-Å., Brismar T.B., Paradossi G. Ultrasonics 2011, 51:40.
20. Llovet J.M., Bruix J. Hepatology 2003, 37:429.
21. Rahman A.M., Yusuf S.W., Ewer M.S. Int. J. Nanomed. 2007, 2:567.
22. Pawar S.K., Badhwar A.J., Kharas F., Khandare J.J., Vavia P.R. Int. J. Pharm. 2012, 436:183.
23. Hu C.M., Zhang L. Curr. Drug Metab. 2009, 10:836.
24. Kim E.M., Jeong H.J., Park I.K., Cho C.S., Kim C.G., Bom H.S. J. Nucl. Med. 2005, 46:141.
25. Cavalieri F., Hamassi El A., Chiessi E., Paradossi G., Villa R., Zaffaroni N. Biomacromology 2006, 7:604.
26. Vold I.M.N., Christensen B.E. Carbohydr. Res. 2005, 340:679.
27. Jiang H.L., Kwon J.T., Kim Y.K., Kim E.M., Arote R., Jeong H.J., Nah J.W., Choi Y.J., Akaike T., Cho M.H., Cho C.S. Gene Ther. 2007, 14:1389.
28. Sivakumar S., Bansal V., Cortez C., Chang S.F., Zelikin A.N., Caruso F. Adv. Mater. 2009, 21:1820.
29. Gianni L., Viganò L., Locatelli A., Capri G., Gianni A., Tarenzi E., Bonadonna G. J. Clin. Oncol. 1997, 15:1906.
30. Grabarek Z., Gergely J. Anal. Biochem. 1990, 185:131.
31. Rinaudo M. Prog. Polym. Sci. 2006, 31:603.
32. Wu J., Liu P., Zhu J.L., Maddukuri S., Zern M.A. Hepatology 1998, 27:772.
33. Freitas R.A. Nanomedicine, Vol 1: Basic Capabilities. Arteriovenous Microcirculation 1999, Landes Biosciences, Georgetown, (Chapter 8).
34. Rogers J. Update Anaesth. 1999, 10:1.
35. Fernandez P., Pretzl M., Fery A., Tzvetkov G., Fink R. Ultrasound Contrast Agents. Targeting and Processing Methods for Theranostics 2010, Springer-Verlag, Milan, (Chapter 9). G. Paradossi, P. Pellegretti, A. Trucco (Eds.).
36. Galbiati A., Tabolacci C., Morozzo della Rocca B., Beninati S., Desideri A., Paradossi G. Mater. Sci. Eng. C 2011, 31:1653.
37. Galbiati A., Tabolacci C., Morozzo della Rocca B., Mattioli P., Beninati S., Paradossi G., Desideri A. Bioconjug. Chem. 2011, 22:1066.
38. Cerroni B., Chiessi E., Margheritelli S., Oddo L., Paradossi G. Biomacromology 2011, 12:593.
39. Jiang H.L., Kwon J.T., Kim Y.K., Kim E.M., Arote R., Jeong H.J., Nah J.W., Choi Y.J., Akaike T., Cho M.H., Cho C.-S. Gene Ther. 2007, 14:1389.
40. Wang S.L., Yu F.B., Jiang T.Y., Sun C.S., Wang T., Zhang J.H. J. Drug Target. 2008, 16:233.
41. Postema M., Gilja O.H. Curr. Pharm. Biotechnol. 2007, 8:355.
42. Mitragotri S. Nat. Rev. Drug Discov. 2005, 4:255.
43. Mizuno Y., Iwata H., Takagi H., Yoshikawa S., Umeda Y., Matsuno Y., Mori Y., Takemura H. J. Surg. Res. 2005, 124:312.
44. Marin A., Sun H., Husseini G.A., Pitt W.G., Christensen D.A., Rapoport N.Y. J. Control. Release 2002, 84:39.